Novel Nutrient Functions and Sensing Mechanisms
新颖的营养功能和传感机制
基本信息
- 批准号:10799400
- 负责人:
- 金额:$ 21.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-01 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAgonistAmino AcidsAnimalsAntibioticsApplications GrantsBacteriaBehaviorBindingCaenorhabditis elegansCardiovascular DiseasesCell WallCellsComplexDataDevelopmentDisaccharidesDiseaseEnterobactinEpithelial CellsEquipmentEventFatty AcidsFibroblastsFundingGenetic ScreeningGenus HippocampusGoalsGrantHealthHomeostasisHumanIntestinesMammalian CellMeasuresMedicalMetabolic DiseasesMitochondriaMusNematodaNeurodegenerative DisordersNucleotidesNutrientOxidative PhosphorylationOxidative StressPatientsPeptidoglycanPhysiologicalPhysiologyPropertyRepressionResearchRespirationRoleSiderophoresTissuescell typecommensal microbesdetection of nutrienthuman diseaseinnovationintestinal epitheliummitochondrial dysfunctionnovelresponse
项目摘要
Project Summary
In our original proposal for the R35 grant application, we described the two major goals of the research
in the field of nutrient function and sensing. One is to discover nutrient value, or the benefits, of specific
bacteria-produced metabolites on human physiology, which had been predicted by the symbiotic
relationship between commensal microbes and host animals. The second goal was to uncover novel
mechanisms that regulate specific physiological events in response to deficiency of specific nutrients that
include fatty acids, nucleotides, and amino acids. These studies address fundamental questions that are
closely related to human health. For this "Supplement Application" that aims to acquire funding for
purchasing a piece of equipment to measure oxidative respiration in animal cells, the research strategy
mainly focuses on the first goal. Using innovative genetic screens in the nematode C. elegans, we have
identified unexpected beneficial roles of certain bacterial metabolites, including the siderophore enterobactin
and bacterial cell wall components peptidoglycan muropeptides, on animal development and behaviors.
Supported by the R35 grant and its R01 precursor grant, we have made exciting progress in understanding
the mechanisms underlying these novel functions. Both molecules enter the mitochondria of host intestinal
cells, bind to ATP synthase, and promote basic mitochondrial functions. In the case of muropeptides, we
have found that beneficial molecules are disaccharide muropeptides containing a short AA chain, and they
enter mitochondria of intestinal cells to repress oxidative stress. Strikingly, muropeptides execute this role
by binding to multiple subunits of ATP synthase, which consequently stabilizes the complex and promotes
its activity. This finding defined the first agonist of the ATP synthase. More recent studies using cultured
human intestinal epithelial cells, fibroblasts from a disease patient, and mice treated with antibiotics have
clearly indicated the roles of muropeptides in promoting oxidative phosphorylation and suppressing
oxidative stress in mammalian cells. In the next several years, we will continue to expand the analyses on
potent muropeptides to understand its structural property, its role in promoting oxidative phosphorylation in
different mammalian tissues, and its potential effect in suppressing mitochondrial dysfunction in disease
cells and mice. Such studies are of high medical significance, as mitochondrial dysfunction is well known to
be associated with a broad range of human diseases including major neurodegenerative, cardiovascular,
and metabolic diseases. We also plan to explore potential roles of other metabolites and nutrient sensing
mechanisms in mitochondrial homeostasis. Having a Seahorse Analyzer to examine oxidative respiration
would greatly facilitate these proposed studies on mitochondrial functions.
项目摘要
在我们最初的R35拨款申请提案中,我们描述了研究的两个主要目标
在营养功能和传感领域。一个是发现营养价值,或利益,
细菌产生的代谢产物对人体生理学的影响,这已经被共生理论所预测。
微生物与宿主动物的关系。第二个目标是发现新的
调节特定生理事件的机制,以响应特定营养素的缺乏,
包括脂肪酸、核苷酸和氨基酸。这些研究解决了一些基本问题,
与人类健康密切相关。对于这一“补充申请”,旨在获得资金,
购买一台设备来测量动物细胞中的氧化呼吸,
主要集中在第一个目标上。在线虫C.优雅,我们有
确定了某些细菌代谢物的意外有益作用,包括铁载体肠杆菌素
和细菌细胞壁组分肽聚糖胞肽,对动物发育和行为的影响。
在R35赠款及其R01前体赠款的支持下,我们在理解和理解方面取得了令人兴奋的进展。
这些新功能背后的机制。这两种分子都进入宿主肠道的线粒体,
细胞,结合ATP合酶,并促进基本的线粒体功能。在尿肽的情况下,我们
已经发现有益分子是含有短AA链的二糖胞肽,并且他们
进入肠细胞的线粒体以抑制氧化应激。引人注目的是,
通过与ATP合酶的多个亚基结合,从而稳定复合物并促进
其活动。这一发现定义了ATP合酶的第一个激动剂。最近的研究使用培养的
人肠上皮细胞、来自疾病患者的成纤维细胞和用抗生素治疗的小鼠,
清楚地表明,在促进氧化磷酸化和抑制
哺乳动物细胞中的氧化应激。在未来几年,我们将继续扩大对
有效的muropeptides了解其结构特性,其作用,促进氧化磷酸化,
不同的哺乳动物组织,及其在抑制疾病中线粒体功能障碍的潜在作用
细胞和小鼠。这些研究具有很高的医学意义,因为众所周知线粒体功能障碍会导致
与广泛的人类疾病相关,包括主要的神经变性,心血管,
和代谢性疾病。我们还计划探索其他代谢物和营养传感的潜在作用
线粒体内稳态的机制。使用海马分析仪检查氧化呼吸
将大大促进这些拟议中的线粒体功能研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MIN HAN其他文献
MIN HAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MIN HAN', 18)}}的其他基金
Novel Nutrient Functions and Sensing Mechanisms
新颖的营养功能和传感机制
- 批准号:
10318176 - 财政年份:2021
- 资助金额:
$ 21.99万 - 项目类别:
Novel Nutrient Functions and Sensing Mechanisms
新颖的营养功能和传感机制
- 批准号:
10535436 - 财政年份:2021
- 资助金额:
$ 21.99万 - 项目类别:
Mechanism by which fatty acid metabolism impacts muscle maintenance
脂肪酸代谢影响肌肉维持的机制
- 批准号:
9977128 - 财政年份:2019
- 资助金额:
$ 21.99万 - 项目类别:
Mechanism by which fatty acid metabolism impacts muscle maintenance
脂肪酸代谢影响肌肉维持的机制
- 批准号:
10203825 - 财政年份:2019
- 资助金额:
$ 21.99万 - 项目类别:
Mechanism by which fatty acid metabolism impacts muscle maintenance
脂肪酸代谢影响肌肉维持的机制
- 批准号:
9814979 - 财政年份:2019
- 资助金额:
$ 21.99万 - 项目类别:
Mechanism by which fatty acid metabolism impacts muscle maintenance
脂肪酸代谢影响肌肉维持的机制
- 批准号:
10436839 - 财政年份:2019
- 资助金额:
$ 21.99万 - 项目类别:
Mechanism by which fatty acid metabolism impacts muscle maintenance
脂肪酸代谢影响肌肉维持的机制
- 批准号:
10656381 - 财政年份:2019
- 资助金额:
$ 21.99万 - 项目类别:
COMBINED EXCITATION AND PARTIAL SATURATION TO REDUCE INFLOW ENHANCEMENT
结合励磁和部分饱和来减少流入增强
- 批准号:
8362939 - 财政年份:2011
- 资助金额:
$ 21.99万 - 项目类别:
TSENSE ACCELERATED BILATERAL 3D SPIRAL BREAST IMAGING
TSENSE 加速双边 3D 螺旋乳房成像
- 批准号:
8169832 - 财政年份:2010
- 资助金额:
$ 21.99万 - 项目类别:
TSENSE ACCELERATED BILATERAL 3D SPIRAL BREAST IMAGING
TSENSE 加速双边 3D 螺旋乳房成像
- 批准号:
7955358 - 财政年份:2009
- 资助金额:
$ 21.99万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 21.99万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 21.99万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 21.99万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 21.99万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 21.99万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 21.99万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 21.99万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 21.99万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 21.99万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 21.99万 - 项目类别: